Tomophase, a developer of bronchoscopic-based systems for interventional pulmonology, has received ninth patent from the US Patent and Trademark Office for integrated systems.
This new patent sets forth designs and techniques for producing the first and only integrated systems that combine the trusted imaging capabilities of a CT scan, and optical probing with proven technology for therapeutic treatment utilizing electromagnetic radiation (e.g. laser, RF, or microwave).
The integrated workstation concept combines the utility of computed tomography (CT) for detecting/locating small early-stage solitary pulmonary nodules (SPNs), with the ability of optical coherence tomography imaging system (OCTIS) to provide images of the nodules allowing the clinician to make a judgement.
Tomophase Ralph Johnston president and CEO said combining the benefits of OCTIS and CT imaging with the therapeutic capability of laser and radio frequency ablation will provide a new, previously unavailable imaging and treatment modality for patients and clinicians.